U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07294274) titled 'Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke' on Nov. 27.

Brief Summary: Post-stroke depression (PSD) is the most common neuropsychiatric disorder after a stroke, with an incidence rate of 20% to 60%. PSD is not only associated with higher mortality rates, poorer recovery, more obvious cognitive impairments, greater economic burdens, and lower quality of life, but also brings additional medical expenses and care pressure to families. Society also needs to bear higher medical costs. Currently, the early diagnosis of PSD is difficult, which may lead to poor prognosis after strok...